William F. Daniel - Apr 28, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role: Director
Signature: /s/ Meghanne Downes, Attorney-in-Fact
Stock symbol: HZNP
Transactions as of: Apr 28, 2023
Transactions value $: -$208,870
Form type: 4
Date filed: 5/2/2023, 07:24 PM
Previous filing: May 2, 2022
Next filing: Jul 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise		+3.91K	+13.1%		33.8K	Apr 28, 2023	Direct	F1, F2
transaction	HZNP	Ordinary Shares	Tax liability	-$209K	-1.88K	-5.56%	$111.16	31.9K	Apr 28, 2023	Direct
holding	HZNP	Ordinary Shares						47.7K	Apr 28, 2023	By Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units	Options Exercise	$0	-3.91K	-100%	$0.00^*	0	Apr 28, 2023	Ordinary Shares	3.91K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2	29,881 Ordinary Shares previously reported as held by Trust held directly.